A brief history of familial Mediterranean fever

References

1. ↵
   1. Reimann HA

   (1951) Periodic disease. Medicine 30:3.

   OpenUrl
2. ↵
   1. Heberden W

   (1802) Commentaries on history and care of disease (Wells and Lilly, London (UK)), p 151.
3. 1. Osler W

   (1895) On the visceral manifestations of erythema multiforme. Am J Med Sci 110:629.

   OpenUrlCrossRef
4. ↵
   1. Janeway TC,
   2. Mosenthal HO

   (1908) An unusual paroxysmal syndrome, probably allied to recurrent vomiting, with a study of the nitrogen metabolism. Arch Intern Med 2:214–225.

   OpenUrl
5. ↵
   1. Siegal S

   (1945) Benign paroxysmal peritonitis. Ann Intern Med 23:1–21.

   OpenUrlWeb of Science
6. ↵
   1. Reimann HA

   (1948) Periodic disease. JAMA 136:239–244.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   1. Reimann HA

   (1964) Perplexities of a periodic entity. JAMA 190:241.

   OpenUrlCrossRefPubMed
8. ↵
   1. Cattan R,
   2. Mamou H

   (1951) 14 Cases of periodic disease, 8 of which are complicated by kidney diseases. Bull Mem Soc Med Hop Paris 67:1104–1107.

   OpenUrlPubMed
9. ↵
   1. Tuqan NA

   (1958) Periodic disease: a clinicopathologic study. Ann Intern Med 49:885–899.

   OpenUrlPubMedWeb of Science
10. ↵
    1. Heller H,
    2. Sohar E,
    3. Sherf L

    (1958) Familial Mediterranean fever. AMA Arch Intern Med 102:50–71.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. Daccak M

    (1966) Periodic peritonitis, analysis of 19 cases. Diseases of the Colon & Rectum 9:168–172.

    OpenUrl
12. ↵
    (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell 90:797–807.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    1. French FMF Consortium

    (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17:25–31.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    1. Hartung EF

    (1954) History of the use of colchicum and related Medicaments in gout. Ann Rheum Dis 13:190–200.

    OpenUrlFREE Full Text
15. ↵
    1. Goldfinger SE

    (1972) Colchicine for familial Mediterranean fever. N Engl J Med 287:1302.

    OpenUrlPubMedWeb of Science
16. ↵
    1. Goldstein RC,
    2. Schwabe AD

    (1974) Prophylactic colchicine therapy in familial Mediterranean fever. A controlled, double-blind study. Ann Intern Med 81:792–794.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    1. Zemer D,
    2. Revach M,
    3. Pras M,
    4. Modan B,
    5. Schor S,
    6. Sohar E,
    7. et al.

    (1974) A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Engl J Med 291:932–934.

    OpenUrlCrossRefPubMedWeb of Science
18. ↵
    1. Dinarello CA,
    2. Chusid MJ,
    3. Fauci AS,
    4. Gallin JI,
    5. Dale DC,
    6. Wolff SM

    (1976) Effect of prophylactic colchicine therapy on leukocyte function in patients with familial Mediterranean fever. Arthritis Rheum 19:618–622.

    OpenUrlPubMedWeb of Science
19. ↵
    1. Martinon F,
    2. Burns K,
    3. Tschopp J

    (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10:417–426.

    OpenUrlCrossRefPubMedWeb of Science
20. ↵
    1. Papin S,
    2. Cuenin S,
    3. Agostini L,
    4. Martinon F,
    5. Werner S,
    6. Beer HD,
    7. et al.

    (2007) The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ 14:1457–1466.

    OpenUrlCrossRefPubMedWeb of Science